Ameriprise
REVS icon

Ameriprise’s Columbia Research Enhanced Value ETF REVS Stock Holding History

Ameriprise’s Portfolio REVS Stock Details REVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-234,550
Closed -$4.22M – 3771
2020
Q2 		$4.22M Hold
234,550
– – ﹤0.01% 2181
2020
Q1 		$3.68M Buy
+234,550
New +$4.56M ﹤0.01% 2111

Other funds holding REVS

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameriprise's REVS Position: Q3 2020 in Review

Ameriprise sold out of Columbia Research Enhanced Value ETF (REVS) in Q3 2020, closing a stake of 234,550 shares — an estimated $4.22M sold.

Ameriprise first reported a position in REVS in Q1 2020 and held it in 2 quarters. The position peaked at $4.22M in Q2 2020. 1 fund tracked by Wall St. Rank holds REVS as of Q3 2020.

  • Ameriprise reported no remaining Columbia Research Enhanced Value ETF position as of Q3 2020 after selling out during the quarter.
  • Ameriprise sold 234,550 Columbia Research Enhanced Value ETF shares in Q3 2020, an estimated $4.22M.
  • Ameriprise first reported a position in Columbia Research Enhanced Value ETF in Q1 2020 and held it in 2 quarters.
  • Ameriprise's Columbia Research Enhanced Value ETF position peaked at $4.22M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q3 2020.

Based on Ameriprise's 13F filing for Q3 2020, filed 16 Nov 2020.